injectable therapeutics which form a biodegradable depot at the injection site. This approach is designed to release active compounds over multi-month periods and reduce the frequency of dosing. Innovarus aims to lessen treatment burden for patients while improving the use of healthcare resources. It collaborates with academic institutions, clinical professionals, and other life-science organizations to advance formulations from pre-clinical development toward clinical application.